
|Articles|November 1, 2003
HAART's Impact on Care
Las Vegas -- The landscape of dermatologic diseases manifested by HIV-positive (HIV+) patients has changed in the era of highly active antiretroviral therapy (HAART), said Clay J. Cockerell, M.D., at the Fall Clinical Dermatology Conference.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
2
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
3
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
4
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
5











